Drug Safety
Leading citation impact metric from Clarivate Journal Citation Reports
115 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.9) | 🔵 Computed |
| 2025 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 3.8) | 🔵 Computed |
| 2024 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4) | 🔵 Computed |
| 2023 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4.2) | 🔵 Computed |
| 2022 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.228) | 🔵 Computed |
| 2021 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.606) | 🔵 Computed |
| 2020 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 3.442) | 🔵 Computed |
| 2019 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 3.526) | 🔵 Computed |
| 2018 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 3.585) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Drug Safety is the official journal of the International Society of Pharmacovigilance. The journal includes: Overviews of contentious or emerging issues. Comprehensive narrative reviews that provide an authoritative source of information on epidemiology, clinical features, prevention and management of adverse effects of individual drugs and drug classes. In-depth benefit-risk assessment of adverse effect and efficacy data for a drug in a defined therapeutic area. Systematic reviews (with or without meta-analyses) that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement. Original research articles reporting the results of well-designed studies in disciplines such as pharmacoepidemiology, pharmacovigilance, pharmacology and toxicology, and pharmacogenomics. Editorials and commentaries on topical issues. Additional digital features (including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations) can be published with articles; these are designed to increase the visibility, readership and educational value of the journal’s content. In addition, articles published in Drug Safety Drugs may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand important medical advances.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
PHARMACOLOGY & PHARMACY | JCRSCIE | 49/356 | Q1 |
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | JCRSCIE | 34/443 | Q1 |
TOXICOLOGY | JCRSCIE | 12/106 | Q1 |
PHARMACOLOGY & PHARMACY | JCISCIE | 43/356 | Q1 |
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | JCISCIE | 46/443 | Q1 |
TOXICOLOGY | JCISCIE | 11/106 | Q1 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 66 | 31 |
| 2025 | 3.8 | 133 | 400 |
| 2024 | 4 | 117 | 1,533 |
| 2023 | 4.2 | 121 | 1,521 |
| 2022 | 5.228 | 129 | 2,453 |
| 2021 | 5.606 | 105 | 2,104 |
| 2020 | 3.442 | 138 | 3,989 |
| 2019 | 3.526 | 130 | 4,641 |
| 2018 | 3.585 | 132 | 3,856 |
| 2017 | — | 138 | 4,419 |
| 2016 | — | 113 | 4,035 |
| 2015 | — | 120 | 6,129 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Drug Safety
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics